Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$0.98−0.06 (-5.77%)
Close on Nov 17, 2026Market cap $12.10MP/E –Yield –
Pluri pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Pluri
Pluri has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?